Jensen I, Zacherle E, Blanchette C, Zhang J, Yin W. 2016. Evaluating cost benefits of combination therapies for advanced melanoma. Drugs Context 5(Jul 15):212297; doi: 10.7573/dic.212297. PMID: 27540409.